Taken together, our data strengthen the role of ZNF521 in the regulation of the immature compartment of malignant hematopoiesis, which, by altering the gene expression landscape, contributes to the development and/or maintenance of AML acting in concert with the MLL-AF9 fusion oncogene. This evidence concerns the gene ZNF521 and acute myeloid leukemia.